HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mutational analysis of the proteolytic cleavage site of glycoprotein B (gB) of Marek's disease virus.

Abstract
The Marek's disease virus (MDV) glycoprotein B (gB) precursor, gp100, is proteolytically cleaved into two disulfide-linked subunits, gp60 and gp49. In the gB homologs of most other herpesviruses, a tetrapeptide, Arg-Xaa-Arg-Arg, is immediately upstream from the predicted cleavage site. We have investigated the specificity of the proteolytic cleavage in gp100 by introducing mutations within its predicted cleavage site (Arg-Leu-Arg-Arg) and expressed these mutants in recombinant fowlpox virus (FPV). The results show that all three Arg residues at the predicted cleavage site play an important role in the specific proteolytic cleavage of gp100. Furthermore, we demonstrated that the cleavage of gp100 is not necessary for transport of gB to the cell surface.
AuthorsS Yoshida, L F Lee, N Yanagida, K Nazerian
JournalGene (Gene) Vol. 150 Issue 2 Pg. 303-6 (Dec 15 1994) ISSN: 0378-1119 [Print] Netherlands
PMID7821796 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, Viral
  • DNA Primers
  • Protein Precursors
  • Viral Envelope Proteins
  • glycoprotein B, Marek's disease virus
  • Methionine
  • Endopeptidases
Topics
  • Amino Acid Sequence
  • Animals
  • Antigens, Viral (biosynthesis)
  • Base Sequence
  • Cell Line
  • Consensus Sequence
  • DNA Mutational Analysis
  • DNA Primers
  • Endopeptidases (metabolism)
  • Gene Expression
  • Herpesvirus 2, Gallid (genetics, metabolism)
  • Kinetics
  • Methionine (metabolism)
  • Molecular Sequence Data
  • Mutagenesis, Site-Directed
  • Protein Precursors (metabolism)
  • Protein Processing, Post-Translational
  • Sequence Homology, Amino Acid
  • Substrate Specificity
  • Viral Envelope Proteins (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: